Search for: "AbbVie Inc." Results 41 - 60 of 148
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
AbbVie, Inc., joining the Seventh Circuit in holding that the FTC is not entitled to seek disgorgement under Section 13(b) of the FTC Act. [read post]
10 Aug 2020, 1:16 pm by Angela Mauroni
The pharmaceutical company AbbVie, Inc. has reached a settlement agreement with California over allegations that it violated the state’s Insurance Frauds Prevention Act. [read post]
11 May 2020, 3:59 am by Deb Givens
  Drugmaker AbbVie Inc. has won U.S. antitrust approval to buy Botox maker Allergan, a blockbuster $63 billion deal when it was announced last year, the companies said on Tuesday. [read post]
12 Apr 2020, 6:03 am by Kluwer Patent blogger
” Israel invoked an emergency patent-suspension clause, allowing it to import a generic version of anti-viral drug Kaletra produced by AbbVie Inc. [read post]
30 Sep 2019, 6:08 am by Deb Givens
Federal Trade Commission (FTC) has requested for more information from AbbVie Inc and botox maker Allergan Plc on their $63 billion deal, the companies said on Friday. [read post]
23 Sep 2019, 6:31 am by Deb Givens
Bristol-Myers Squibb’s $74 billion buyout of Celgene Corp. and AbbVie Inc. [read post]
24 Jul 2019, 6:22 am by Philipp Widera
Legal background regarding Arrow-declarations The underlying jurisdiction was established in Arrow Generics v Merck & Co Inc [2007] FSR 39 and approved by the Court of Appeal in Fujifilm v AbbVie [2017] EWCA Civ. 1. [read post]
7 Mar 2019, 12:29 pm by Schachtman
One litigation that showcases the use and misuse of the ASA Statement arose from claims that AbbVie, Inc. [read post]